In this issue:
Long-term safety and efficacy of eptinezumab
Nipocalimab for generalised MG
Safety and efficacy of satralizumab
Risk of cardiovascular disease after anti-CGRP mAbs
Safety of discontinuing DMT
Optimal timing for sNfL and sGFAP assessment
Demographic and geographic trends in MGRM from 1999 to 2022
Final results from the CHAMPTION MG phase 3 trial
Surgical and neurological outcomes of robotic thymectomy
C5IT versus FcRn
Please login below to download this issue (PDF)